<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Otorhinolaryngol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Otorhinolaryngol</journal-id><journal-id journal-id-type="publisher-id">CEO</journal-id><journal-title-group><journal-title>Clinical and Experimental Otorhinolaryngology</journal-title></journal-title-group><issn pub-type="ppub">1976-8710</issn><issn pub-type="epub">2005-0720</issn><publisher><publisher-name>Korean Society of Otorhinolaryngology-Head and Neck Surgery</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24353861</article-id><article-id pub-id-type="pmc">3863670</article-id><article-id pub-id-type="doi">10.3342/ceo.2013.6.4.219</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Protective Role of Trimetazidine Against Neomycin-induced Hair Cell Damage in Zebrafish</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Jiwon</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib><contrib contrib-type="author"><name><surname>Im</surname><given-names>Gi Jung</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib><contrib contrib-type="author"><name><surname>Chae</surname><given-names>Sung Won</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Seung Hoon</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib><contrib contrib-type="author"><name><surname>Kwon</surname><given-names>Soon-Young</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib><contrib contrib-type="author"><name><surname>Jung</surname><given-names>Hak Hyun</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Ah-Young</given-names></name><xref ref-type="aff" rid="A2-ceo-6-219">2</xref></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hae-Chul</given-names></name><xref ref-type="aff" rid="A2-ceo-6-219">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Choi</surname><given-names>June</given-names></name><xref ref-type="aff" rid="A1-ceo-6-219">1</xref></contrib></contrib-group><aff id="A1-ceo-6-219"><label>1</label>Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul, Korea.</aff><aff id="A2-ceo-6-219"><label>2</label>Laboratory of Neurodevelopmental Genetics, Graduate School of Medicine, Korea University, Seoul, Korea.</aff><author-notes><corresp>Corresponding author: June Choi. Department of Otolaryngology-Head and Neck Surgery, Korea University College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-707, Korea. Tel: +82-31-412-5170, Fax: +82-31-412-5174, <email>mednlaw@korea.ac.kr</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>29</day><month>11</month><year>2013</year></pub-date><volume>6</volume><issue>4</issue><fpage>219</fpage><lpage>225</lpage><history><date date-type="received"><day>17</day><month>4</month><year>2012</year></date><date date-type="rev-recd"><day>06</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2013 by Korean Society of Otorhinolaryngology-Head and Neck Surgery.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objectives</title><p>Trimetazidine (TMZ) is known to reduce the generation of oxygen-derived free radicals. The objective of the present study was to evaluate the effects of TMZ on neomycin-induced ototoxicity in transgenic zebrafish (Brn3C: EGFP).</p></sec><sec><title>Methods</title><p>Five-day, postfertilization zebrafish larvae were exposed to 125 &#xB5;M neomycin and one of the following TMZ concentrations for 1 hour: 10 &#xB5;M, 100 &#xB5;M, 500 &#xB5;M, 1,000 &#xB5;M, 1,500 &#xB5;M, or 2,000 &#xB5;M. Hair cells within the neuromasts of the supraorbital (SO1 and SO2), otic (O1), and occipital (OC1) lateral lines were analyzed using fluorescence microscopy and confocal microscopy (n=10). Hair cell survival was calculated as a percentage of hair cells in the control group that were not exposed to neomycin. Ultrastructural changes were evaluated using scanning electron microscopy.</p></sec><sec><title>Results</title><p>TMZ protected against neomycin-induced hair cell loss in the neuromasts (TMZ 1,000 &#xB5;M, 11.2&#xB1;0.4 cells; 125 &#xB5;M neomycin only, 4.2&#xB1;0.5 cells; n=10; <italic>P</italic>&lt;0.05) and decreased the terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) reaction. In the ultrastructural analysis, structures of mitochondria and hair cells within the neuromasts were preserved in zebrafish exposed to 125 &#xB5;M neomycin and 1,000 &#xB5;M TMZ.</p></sec><sec><title>Conclusion</title><p>TMZ attenuated neomycin-induced hair cell loss in zebrafish. The results of this study suggest that neomycin induces apoptosis, and that apoptotic cell death can be prevented by treatment with tremetazidine.</p></sec></abstract><kwd-group><kwd>Trimetazidine</kwd><kwd>Neomycin</kwd><kwd>Ototoxicity</kwd><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group><funding-source country="KR">Korea University</funding-source></award-group></funding-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Aminoglycoside antibiotics have been known to be very effective in treating Gram-negative bacteria [<xref ref-type="bibr" rid="B1-ceo-6-219">1</xref>-<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>]. However, although such antibiotics are effective and are widely available, they have long been known to exhibit nephrotoxicity and ototoxicity [<xref ref-type="bibr" rid="B1-ceo-6-219">1</xref>-<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>]. The former is known to be often reversible, while the latter is irreversible. The ototoxic effects of these drugs include sensorineural hearing loss, which is permanent because the hair cells in the cochlea do not regenerate [<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>]. The incidence of ototoxicity from aminoglycosides has been reported to range from 2% to 25%, which is likely underestimated because of the ambiguity of the symptoms [<xref ref-type="bibr" rid="B2-ceo-6-219">2</xref>].</p><p>The generation of reactive oxygen species (ROS) is one of the earliest events in the process of aminoglycoside ototoxicity. Production of ROS is thought to play a key role in the initiation of hair cell death via oxidative stress [<xref ref-type="bibr" rid="B1-ceo-6-219">1</xref>,<xref ref-type="bibr" rid="B4-ceo-6-219">4</xref>]. Histopathologic studies have shown that the outer hair cells are more sensitive to ototoxic injury than the inner hair cells [<xref ref-type="bibr" rid="B2-ceo-6-219">2</xref>,<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>]. Such histological findings resemble those of apoptotic cell death, which is primarily regulated by the activation of caspases through either internal or external pathways [<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>,<xref ref-type="bibr" rid="B5-ceo-6-219">5</xref>,<xref ref-type="bibr" rid="B6-ceo-6-219">6</xref>]. Despite the protective effects against oxidative stress of many agents that have been studied [<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>,<xref ref-type="bibr" rid="B5-ceo-6-219">5</xref>,<xref ref-type="bibr" rid="B7-ceo-6-219">7</xref>], none has been approved for use in clinical fields.</p><p>Trimetazidine (TMZ), 1-2,3,4 tri-metoxibencil piperazine dihydrochloride, is a clinically available drug used for ischemic heart disease because it prevents cell death secondary to transient myocardial ischemia that occurs during reperfusion [<xref ref-type="bibr" rid="B8-ceo-6-219">8</xref>,<xref ref-type="bibr" rid="B9-ceo-6-219">9</xref>]. Numerous experimental studies have reported that TMZ prevents an excessive release of free radicals, which are particularly toxic to phospholipid membranes and are responsible for the decrease in intracellular adenosin triphosphate (ATP) concentration and the extracellular leakage of potassium and protects mitochondrial function [<xref ref-type="bibr" rid="B8-ceo-6-219">8</xref>,<xref ref-type="bibr" rid="B10-ceo-6-219">10</xref>,<xref ref-type="bibr" rid="B11-ceo-6-219">11</xref>]. Zebrafish have hair cells on the surfaces of their bodies that function as part of the lateral line sensory system [<xref ref-type="bibr" rid="B12-ceo-6-219">12</xref>,<xref ref-type="bibr" rid="B13-ceo-6-219">13</xref>]. The hair cells of neuromasts in the zebrafish lateral line are a useful system for studying hair cell loss after exposure to ototoxic agents [<xref ref-type="bibr" rid="B14-ceo-6-219">14</xref>,<xref ref-type="bibr" rid="B15-ceo-6-219">15</xref>]. Thus, the purpose of the current study was to investigate the effects of TMZ on neomycin-induced ototoxicity in transgenic zebrafish.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Chemicals</title><p>Neomycin and TMZ were purchased from Sigma Chemical Co. (St. Louis, MO, USA).</p></sec><sec><title>Fish preparation and maintenance</title><p>Transgenic zebrafish embryos were produced using paired matings of adult fish maintained at 28.5&#x2103; in a zebrafish facility at Korea University Ansan Hospital. Embryos were maintained at a density of about 50 per 100 mm<sup>2</sup> Petri dish in embryo media (1 mM MgSO4, 120 &#xB5;M KH<sub>2</sub>PO<sub>4</sub>, 74 &#xB5;M Na<sub>2</sub>HPO<sub>4</sub>, 1 mM CaCl<sub>2</sub>, 500 &#xB5;M KCl, 15 &#xB5;M NaCl, and 500 &#xB5;M NaHCO<sub>3</sub> in dH<sub>2</sub>O).</p></sec><sec><title>Examination of neuromasts in zebrafish</title><p>Neomycin solutions were prepared by adding the neomycin powder to the embryo medium. Neomycin has been shown to decrease the viability of neuromasts in a dose-dependent manner. Additionally, a preliminary study showed that neuromasts treated with 125 &#xB5;M neomycin for 1 hour show a viability rate of 50% (data is not shown). Thus, a dose of 125 &#xB5;M neomycin was chosen as an adequate experimental condition for our following studies. For the present experiment, 10 fish were tested at each of the following concentrations of TMZ and repeated three times. The larvae of 5-dpf transgenic zebrafish were simultaneously exposed to 125 &#xB5;M neomycin and one of the following concentrations of TMZ for 1 hour: 10 &#xB5;M, 100 &#xB5;M, 500 &#xB5;M, 1,000 &#xB5;M, 1,500 &#xB5;M, or 2,000 &#xB5;M. After the transgenic zebrafish larvae were exposed to neomycin and TMZ, they were rinsed three times in embryo media and anesthetized with Tricane (3-aminobenzoic acid, 0.4 g/ethyl ester, 100 mL - pH 7, adjustments by Tris buffer) for 5 minutes.</p><p>The zebrafish were mounted with methylcellulose on a depression slide for evaluation under a fluorescence microscope. Hair cells within the neuromasts of the supraorbital (SO1 and SO2), otic (O1), and occipital (OC1) lateral lines were analyzed [<xref ref-type="bibr" rid="B12-ceo-6-219">12</xref>,<xref ref-type="bibr" rid="B13-ceo-6-219">13</xref>,<xref ref-type="bibr" rid="B16-ceo-6-219">16</xref>,<xref ref-type="bibr" rid="B17-ceo-6-219">17</xref>]. The average numbers of hair cells of the SO1, SO2, O1, and OC1 neuromasts were counted for each zebrafish under all experimental and control conditions (n=10) using a fluorescence microscope and confocal microscope (LSM5 PASCAL; Carl Zeiss, Oberkochen, Germany). The fluorescent dye, 2-[4-(dimethylamino) styryl]-N-ethylpyridinium iodide (DASPEI; Invitrogen, Carlsbad, CA, USA), was used as to stain mitochondria within hair cells. Larvae were incubated in the embryo medium containing 0.005% DASPEI for 15 minutes and were analyzed according to the same method as described above.</p></sec><sec><title>Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay</title><p>Apoptosis in the neuromasts was evaluated using the TUNEL method with an in situ cell detection kit (Roche Molecular Biochemicals, Mannheim, Germany), as per the manufacturer's protocol. The transgenic zebrafish larvae were exposed to medium containing 125 &#xB5;M neomycin and 1,000 &#xB5;M TMZ for 1 hour. Thereafter, the larvae were washed with phosphate buffered saline (PBS) and fixed in 4% paraformaldehyde. The larvae were then incubated with 50 &#xB5;L TUNEL reaction mixture (TdT and fluorescein-dUTP) at 37&#x2103; for 1 hour in a humid atmosphere. The zebrafish were then evaluated under a fluorescence microscope (AxioCam MRc5; Carl Zeiss) [<xref ref-type="bibr" rid="B16-ceo-6-219">16</xref>].</p></sec><sec><title>Scanning electron microscopy</title><p>For scanning electron microscopy (SEM), 5-dpf zebrafish larvae exposed to 125 &#xB5;M neomycin and 1,000 &#xB5;M TMZ for 1 hour were prefixed by immersion in 2% glutaraldehyde in 0.1 M phosphate buffer and postfixed for 2 hours in 1% osmic acid dissolved in PBS. Samples were treated in a graded series of ethanol and t-butyl alcohol, dried in a freeze dryer (Hitachi, ES-2030; Hitachi, Tokyo, Japan), platinum-coated using an ion coater (Eiko, IB-5; Eiko, Katsuda, Japan), and observed under an field emission-SEM (Hitachi, S-4700) [<xref ref-type="bibr" rid="B18-ceo-6-219">18</xref>].</p></sec><sec><title>Statistical analysis</title><p>All values are shown as mean&#xB1;SD. For statistical comparisons, one-way analysis of variance was used for multiple comparisons. Results were considered statistically significant at <italic>P</italic>&lt;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><sec><title>The effect of TMZ on hair cells in transgenic zebrafish treated with neomycin</title><p>Four neuromasts, SO1, SO2, O1, and OC1, were evaluated. Treatment of the zebrafish with 125 &#xB5;M neomycin for 1 hour significantly decreased the number of hair cells in the neuromasts. Hair cells from the four neuromasts were counted to investigate the changes after treatment with neomycin and TMZ.</p><p>Confocal microscopy was used to calculate hair cell survival as a percentage of the hair cells present in the control group not exposed to neomycin. While 125 &#xB5;M neomycin significantly decreased the number of neuromast hair cells, TMZ protected against this neomycin-induced hair cell loss (control, 13.1&#xB1;0.9 cells; 125 &#xB5;M neomycin only, 4.2&#xB1;0.5 cells; TMZ 10 &#xB5;M, 4.2&#xB1;0.7 cells; TMZ 100 &#xB5;M, 4.1&#xB1;0.6 cells; TMZ 500 &#xB5;M, 9.4&#xB1;1.1 cells; TMZ 1,000 &#xB5;M, 11.2&#xB1;0.4 cells; TMZ 1,500 &#xB5;M, 10.0&#xB1;0.7 cells; TMZ 2,000 &#xB5;M, 8.7&#xB1;1.7 cells; n=10; <italic>P</italic>&lt;0.05) (<xref ref-type="fig" rid="F1-ceo-6-219">Figs. 1</xref>, <xref ref-type="fig" rid="F2-ceo-6-219">2</xref>).</p><p>Because 1,000 &#xB5;M TMZ was the most effective dose, this concentration was used in the DASPEI and TUNEL assays. DASPEI staining was performed to evaluate mitochondrial damage and revealed that mitochondria within hair cells were protected by TMZ treatment (<xref ref-type="fig" rid="F3-ceo-6-219">Fig. 3</xref>). The TUNEL reaction was used to determine if neomycin induced the death of neuromasts by apoptosis and whether that cell death could be prevented by TMZ treatment. As shown in <xref ref-type="fig" rid="F4-ceo-6-219">Fig. 4</xref>, neomycin increased TUNEL-positive cells, and TMZ treatment decreased TUNEL-positive cells. These results indicate that neomycin promotes apoptotic cell death, and that this apoptosis can be inhibited by TMZ treatment.</p></sec><sec><title>TMZ protects stereocilia and kinocillium in transgenic zebrafish treated with neomycin</title><p><xref ref-type="fig" rid="F5-ceo-6-219">Fig. 5</xref> shows scanning electron micrographs of stereocilia and kinocilium from neomycin- and TMZ-treated zebrafish. Compared to control larvae, exposure to 125 &#xB5;M neomycin for 1 hour resulted in severe morphological damage to hair cells, including loss or fusion of stereocilia and kinocilium. TMZ protected the larvae against neomycin-induced hair cell loss compared to treatment with neomycin alone.</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>The current study evaluated the effect of TMZ to prevent neomycin-induced ototoxicity. Results indicated that concomitant administration of TMZ prevents neomycin-induced hair cell damage in zebrafish. It is known that aminoglycosides appear to generate free radicals within the inner ear, with subsequent permanent damage to sensory cells, resulting in permanent hearing loss [<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>]. The production of ROS is known to be the initiating step of aminoglycoside ototoxicity, which ultimately results in apoptosis [<xref ref-type="bibr" rid="B1-ceo-6-219">1</xref>-<xref ref-type="bibr" rid="B3-ceo-6-219">3</xref>,<xref ref-type="bibr" rid="B6-ceo-6-219">6</xref>]. ROS is thought to occur as a result of aminoglycoside affinity for iron. The drug binds with iron, and the resulting iron-aminoglycoside complex is known to promote the formation of free radicals [<xref ref-type="bibr" rid="B19-ceo-6-219">19</xref>]. Free radicals are known to cause damage to many cells in the body in situations such as inflammation, aging, and reperfusion injury [<xref ref-type="bibr" rid="B2-ceo-6-219">2</xref>,<xref ref-type="bibr" rid="B19-ceo-6-219">19</xref>]. Free radicals can attack a variety of cell components ranging from cell membranes to DNA, causing irreversible damage and cell death. Morphologic features of apoptosis are condensed chromatin, nuclear pyknosis, apoptotic body formation, and cellular dissolution [<xref ref-type="bibr" rid="B2-ceo-6-219">2</xref>]. Numerous studies have attempted to identify a mechanism that protects the inner ear from aminoglycoside ototoxicity. Unfortunately, the United States Food and Drug Administration (FDA) has not yet approved any drugs for the prevention of drug-induced ototoxicity [<xref ref-type="bibr" rid="B16-ceo-6-219">16</xref>]. TMZ is a clinically useful drug used for ischemic heart disease since 1970. It was also demonstrated that TMZ is affective in hepatic ischemia and neurotoxicity caused by cyclosporine [<xref ref-type="bibr" rid="B10-ceo-6-219">10</xref>]. TMZ has been known to decrease the intracellular accumulation of sodium and calcium and to inhibit platelet adhesion-aggregation, neutrophil infiltration, and the generation or activity of oxygen-derived free radicals [<xref ref-type="bibr" rid="B9-ceo-6-219">9</xref>,<xref ref-type="bibr" rid="B20-ceo-6-219">20</xref>,<xref ref-type="bibr" rid="B21-ceo-6-219">21</xref>]. Additionally, TMZ reduces the vasoconstriction mediated by the components released by free radicals. Some researchers have reported a protective effect of TMZ on ROS-induced renal injury during ischemia/reperfusion [<xref ref-type="bibr" rid="B9-ceo-6-219">9</xref>,<xref ref-type="bibr" rid="B22-ceo-6-219">22</xref>]. However, studies of TMZ on hair cell damage are rare.</p><p>The use of the zebrafish in a chemical screen was first described by identification of small molecules that modulate development of the cardiovascular system, central nervous system, neural crest, and ear [<xref ref-type="bibr" rid="B23-ceo-6-219">23</xref>,<xref ref-type="bibr" rid="B24-ceo-6-219">24</xref>]. Subsequent chemical screens have demonstrated a number of different compounds, including novel retinoids, drugs that affect heart rate in a zebrafish mode, chemicals that inhibit melanoma [<xref ref-type="bibr" rid="B24-ceo-6-219">24</xref>-<xref ref-type="bibr" rid="B27-ceo-6-219">27</xref>]. Recently, zebrafish have emerged as a model for studies of hearing and vestibular function [<xref ref-type="bibr" rid="B28-ceo-6-219">28</xref>]. Zebrafish have hair cells that are functionally and structurally similar to mammalian inner ear hair cells. These hair cells are organized into clusters of 5-20 cells, called neuromasts, and are located on the head and along the body (lateral line) [<xref ref-type="bibr" rid="B12-ceo-6-219">12</xref>,<xref ref-type="bibr" rid="B13-ceo-6-219">13</xref>]. The superficial location of hair cells permits easy visualization and manipulation of hair cells in living animals [<xref ref-type="bibr" rid="B1-ceo-6-219">1</xref>]. Hair cells of the lateral line allow for rapid <italic>in vivo</italic> assessment of hair cell death and ototoxic and potentially protective compounds [<xref ref-type="bibr" rid="B14-ceo-6-219">14</xref>-<xref ref-type="bibr" rid="B16-ceo-6-219">16</xref>,<xref ref-type="bibr" rid="B25-ceo-6-219">25</xref>,<xref ref-type="bibr" rid="B28-ceo-6-219">28</xref>]. However, it is important to know some critical differences between zebrafish hair cells and mammalian hair cells. Hair cells of the lateral line lacks stria vascularis in contrast to the inner ear, thus hair cell loss through strial mechanisms cannot be elucidated [<xref ref-type="bibr" rid="B12-ceo-6-219">12</xref>,<xref ref-type="bibr" rid="B24-ceo-6-219">24</xref>,<xref ref-type="bibr" rid="B29-ceo-6-219">29</xref>]. In addition, lateral line hair cells are morphologically and physiologically much more similar to vestibular than cochlear hair cells of the mammalian inner ear. Therefore, any discovery made in zebrafish must be confirmed in mammals prior to translational applications [<xref ref-type="bibr" rid="B12-ceo-6-219">12</xref>,<xref ref-type="bibr" rid="B24-ceo-6-219">24</xref>,<xref ref-type="bibr" rid="B29-ceo-6-219">29</xref>]. In the present study, transgenic zebrafish (Brn3C: EGFP) were used to determine the potential ototoxicity of drugs and to investigate the protective activity of TMZ with regard to neomycin-induced ototoxicity. These transgenic zebrafish have green neuromasts that are visible under a fluorescent microscope without staining [<xref ref-type="bibr" rid="B16-ceo-6-219">16</xref>,<xref ref-type="bibr" rid="B30-ceo-6-219">30</xref>]. Exposure to 125 &#xB5;M neomycin for 1 hour resulted in apoptotic cell death, reduction in mitochondrial injury, and severe morphological damage to stereocilia and kinocilium. However, TMZ provided nearly complete protection against neomycin-induced hair cell damage. These results suggest that neomycin induces apoptosis, and that apoptotic cell death was prevented with TMZ treatment.</p><p>In conclusion, TMZ attenuated neomycin-induced hair cell damage by reducing the amount of free radicals. Further studies are currently ongoing to define the functional effects of TMZ <italic>in vivo</italic>.</p></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>This research was supported by a Korea University Grant, by the Soo ENT Clinic and the Communication Disorders Center, Korea University.</p></ack><fn-group><fn fn-type="conflict"><p>No potential conflict of interest relevant to this article was reported.</p></fn></fn-group><ref-list><ref id="B1-ceo-6-219"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warchol</surname><given-names>ME</given-names></name></person-group><article-title>Cellular mechanisms of aminoglycoside ototoxicity</article-title><source>Curr Opin Otolaryngol Head Neck Surg</source><year>2010</year><month>10</month><volume>18</volume><issue>5</issue><fpage>454</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">20717031</pub-id></element-citation></ref><ref id="B2-ceo-6-219"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzi</surname><given-names>MD</given-names></name><name><surname>Hirose</surname><given-names>K</given-names></name></person-group><article-title>Aminoglycoside ototoxicity</article-title><source>Curr Opin Otolaryngol Head Neck Surg</source><year>2007</year><month>10</month><volume>15</volume><issue>5</issue><fpage>352</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">17823553</pub-id></element-citation></ref><ref id="B3-ceo-6-219"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selimoglu</surname><given-names>E</given-names></name></person-group><article-title>Aminoglycoside-induced ototoxicity</article-title><source>Curr Pharm Des</source><year>2007</year><month>1</month><volume>13</volume><issue>1</issue><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">17266591</pub-id></element-citation></ref><ref id="B4-ceo-6-219"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Talaska</surname><given-names>AE</given-names></name><name><surname>Schacht</surname><given-names>J</given-names></name></person-group><article-title>New developments in aminoglycoside therapy and ototoxicity</article-title><source>Hear Res</source><year>2011</year><month>11</month><volume>281</volume><issue>1-2</issue><fpage>28</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">21640178</pub-id></element-citation></ref><ref id="B5-ceo-6-219"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>HH</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>JY</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Im</surname><given-names>GJ</given-names></name><name><surname>Chae</surname><given-names>SW</given-names></name></person-group><article-title>Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell line</article-title><source>Hear Res</source><year>2011</year><month>12</month><volume>282</volume><issue>1-2</issue><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">21979311</pub-id></element-citation></ref><ref id="B6-ceo-6-219"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybak</surname><given-names>LP</given-names></name><name><surname>Kelly</surname><given-names>T</given-names></name></person-group><article-title>Ototoxicity: bioprotective mechanisms</article-title><source>Curr Opin Otolaryngol Head Neck Surg</source><year>2003</year><month>10</month><volume>11</volume><issue>5</issue><fpage>328</fpage><lpage>333</lpage><pub-id pub-id-type="pmid">14502062</pub-id></element-citation></ref><ref id="B7-ceo-6-219"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forge</surname><given-names>A</given-names></name><name><surname>Schacht</surname><given-names>J</given-names></name></person-group><article-title>Aminoglycoside antibiotics</article-title><source>Audiol Neurootol</source><year>2000</year><season>Jan-Feb</season><volume>5</volume><issue>1</issue><fpage>3</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">10686428</pub-id></element-citation></ref><ref id="B8-ceo-6-219"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De la Cruz Rodriguez</surname><given-names>LA</given-names></name><name><surname>Araujo</surname><given-names>CR</given-names></name><name><surname>Posleman</surname><given-names>SE</given-names></name><name><surname>Rey</surname><given-names>MR</given-names></name></person-group><article-title>Attenuation of gentamicin-induced nephrotoxicity: trimetazidine versus N-acetyl cysteine</article-title><source>J Appl Toxicol</source><year>2010</year><month>5</month><volume>30</volume><issue>4</issue><fpage>343</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">20063365</pub-id></element-citation></ref><ref id="B9-ceo-6-219"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Chander</surname><given-names>V</given-names></name><name><surname>Chopra</surname><given-names>K</given-names></name></person-group><article-title>Carvedilol and trimetazidine attenuates ferric nitrilotriacetate-induced oxidative renal injury in rats</article-title><source>Toxicology</source><year>2003</year><month>9</month><volume>191</volume><issue>2-3</issue><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">12965117</pub-id></element-citation></ref><ref id="B10-ceo-6-219"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unal</surname><given-names>OF</given-names></name><name><surname>Ghoreishi</surname><given-names>SM</given-names></name><name><surname>Atas</surname><given-names>A</given-names></name><name><surname>Akyurek</surname><given-names>N</given-names></name><name><surname>Akyol</surname><given-names>G</given-names></name><name><surname>Gursel</surname><given-names>B</given-names></name></person-group><article-title>Prevention of gentamicin induced ototoxicity by trimetazidine in animal model</article-title><source>Int J Pediatr Otorhinolaryngol</source><year>2005</year><month>2</month><volume>69</volume><issue>2</issue><fpage>193</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">15656952</pub-id></element-citation></ref><ref id="B11-ceo-6-219"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarnieri</surname><given-names>C</given-names></name><name><surname>Muscari</surname><given-names>C</given-names></name></person-group><article-title>Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle</article-title><source>Cardiovasc Drugs Ther</source><year>1990</year><volume>4</volume><issue>Suppl 4</issue><fpage>814</fpage><lpage>815</lpage><pub-id pub-id-type="pmid">1965528</pub-id></element-citation></ref><ref id="B12-ceo-6-219"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>HC</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name><name><surname>Rubel</surname><given-names>EW</given-names></name></person-group><article-title>Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line</article-title><source>Hear Res</source><year>2007</year><month>11</month><volume>233</volume><issue>1-2</issue><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">17709218</pub-id></element-citation></ref><ref id="B13-ceo-6-219"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ton</surname><given-names>C</given-names></name><name><surname>Parng</surname><given-names>C</given-names></name></person-group><article-title>The use of zebrafish for assessing ototoxic and otoprotective agents</article-title><source>Hear Res</source><year>2005</year><month>10</month><volume>208</volume><issue>1-2</issue><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">16014323</pub-id></element-citation></ref><ref id="B14-ceo-6-219"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>HC</given-names></name><name><surname>Cunningham</surname><given-names>LL</given-names></name><name><surname>Francis</surname><given-names>SP</given-names></name><name><surname>Brandon</surname><given-names>CS</given-names></name><name><surname>Simon</surname><given-names>JA</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle</article-title><source>J Assoc Res Otolaryngol</source><year>2009</year><month>6</month><volume>10</volume><issue>2</issue><fpage>191</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">19241104</pub-id></element-citation></ref><ref id="B15-ceo-6-219"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zon</surname><given-names>LI</given-names></name><name><surname>Peterson</surname><given-names>RT</given-names></name></person-group><article-title>In vivo drug discovery in the zebrafish</article-title><source>Nat Rev Drug Discov</source><year>2005</year><month>1</month><volume>4</volume><issue>1</issue><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">15688071</pub-id></element-citation></ref><ref id="B16-ceo-6-219"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Im</surname><given-names>GJ</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Chae</surname><given-names>SW</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Kwon</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish</article-title><source>J Appl Toxicol</source><year>2013</year><month>2</month><volume>33</volume><issue>2</issue><fpage>125</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">22147442</pub-id></element-citation></ref><ref id="B17-ceo-6-219"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raible</surname><given-names>DW</given-names></name><name><surname>Kruse</surname><given-names>GJ</given-names></name></person-group><article-title>Organization of the lateral line system in embryonic zebrafish</article-title><source>J Comp Neurol</source><year>2000</year><month>5</month><volume>421</volume><issue>2</issue><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">10813781</pub-id></element-citation></ref><ref id="B18-ceo-6-219"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>TY</given-names></name><name><surname>Son</surname><given-names>SW</given-names></name><name><surname>Choi</surname><given-names>BJ</given-names></name><name><surname>Park</surname><given-names>CH</given-names></name></person-group><article-title>A study of structure of the sucker of Common freshwater goby (Rhinogobius brunneus) and Triden goby (Tridentiger brevispinis)</article-title><source>Korean J Electron Microsc</source><year>2002</year><month>3</month><volume>32</volume><issue>1</issue><fpage>57</fpage><lpage>66</lpage></element-citation></ref><ref id="B19-ceo-6-219"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Priuska</surname><given-names>EM</given-names></name><name><surname>Schacht</surname><given-names>J</given-names></name></person-group><article-title>Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex</article-title><source>Biochem Pharmacol</source><year>1995</year><month>11</month><volume>50</volume><issue>11</issue><fpage>1749</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">8615852</pub-id></element-citation></ref><ref id="B20-ceo-6-219"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>FM</given-names></name><name><surname>Tanda</surname><given-names>K</given-names></name><name><surname>Kus</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>TJ</given-names></name></person-group><article-title>Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits</article-title><source>J Cardiovasc Pharmacol</source><year>1993</year><month>12</month><volume>22</volume><issue>6</issue><fpage>828</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">7509900</pub-id></element-citation></ref><ref id="B21-ceo-6-219"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Banani</surname><given-names>H</given-names></name><name><surname>Bernard</surname><given-names>M</given-names></name><name><surname>Baetz</surname><given-names>D</given-names></name><name><surname>Cabanes</surname><given-names>E</given-names></name><name><surname>Cozzone</surname><given-names>P</given-names></name><name><surname>Lucien</surname><given-names>A</given-names></name><etal/></person-group><article-title>Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine: comparison between low- and zero-flow ischaemia</article-title><source>Cardiovasc Res</source><year>2000</year><month>9</month><volume>47</volume><issue>4</issue><fpage>688</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">10974217</pub-id></element-citation></ref><ref id="B22-ceo-6-219"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onbasili</surname><given-names>AO</given-names></name><name><surname>Yeniceriglu</surname><given-names>Y</given-names></name><name><surname>Agaoglu</surname><given-names>P</given-names></name><name><surname>Karul</surname><given-names>A</given-names></name><name><surname>Tekten</surname><given-names>T</given-names></name><name><surname>Akar</surname><given-names>H</given-names></name><etal/></person-group><article-title>Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures</article-title><source>Heart</source><year>2007</year><month>6</month><volume>93</volume><issue>6</issue><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">17065180</pub-id></element-citation></ref><ref id="B23-ceo-6-219"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>RT</given-names></name><name><surname>Link</surname><given-names>BA</given-names></name><name><surname>Dowling</surname><given-names>JE</given-names></name><name><surname>Schreiber</surname><given-names>SL</given-names></name></person-group><article-title>Small molecule developmental screens reveal the logic and timing of vertebrate development</article-title><source>Proc Natl Acad Sci U S A</source><year>2000</year><month>11</month><volume>97</volume><issue>24</issue><fpage>12965</fpage><lpage>12969</lpage><pub-id pub-id-type="pmid">11087852</pub-id></element-citation></ref><ref id="B24-ceo-6-219"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ou</surname><given-names>H</given-names></name><name><surname>Simon</surname><given-names>JA</given-names></name><name><surname>Rubel</surname><given-names>EW</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name></person-group><article-title>Screening for chemicals that affect hair cell death and survival in the zebrafish lateral line</article-title><source>Hear Res</source><year>2012</year><month>6</month><volume>288</volume><issue>1-2</issue><fpage>58</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">22310494</pub-id></element-citation></ref><ref id="B25-ceo-6-219"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachidanandan</surname><given-names>C</given-names></name><name><surname>Yeh</surname><given-names>JR</given-names></name><name><surname>Peterson</surname><given-names>QP</given-names></name><name><surname>Peterson</surname><given-names>RT</given-names></name></person-group><article-title>Identification of a novel retinoid by small molecule screening with zebrafish embryos</article-title><source>PLoS One</source><year>2008</year><month>4</month><volume>3</volume><issue>4</issue><fpage>e1947</fpage><pub-id pub-id-type="pmid">18398471</pub-id></element-citation></ref><ref id="B26-ceo-6-219"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milan</surname><given-names>DJ</given-names></name><name><surname>Peterson</surname><given-names>TA</given-names></name><name><surname>Ruskin</surname><given-names>JN</given-names></name><name><surname>Peterson</surname><given-names>RT</given-names></name><name><surname>MacRae</surname><given-names>CA</given-names></name></person-group><article-title>Drugs that induce repolarization abnormalities cause bradycardia in zebrafish</article-title><source>Circulation</source><year>2003</year><month>3</month><volume>107</volume><issue>10</issue><fpage>1355</fpage><lpage>1358</lpage><pub-id pub-id-type="pmid">12642353</pub-id></element-citation></ref><ref id="B27-ceo-6-219"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>RM</given-names></name><name><surname>Cech</surname><given-names>J</given-names></name><name><surname>Ratanasirintrawoot</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Rahl</surname><given-names>PB</given-names></name><name><surname>Burke</surname><given-names>CJ</given-names></name><etal/></person-group><article-title>DHODH modulates transcriptional elongation in the neural crest and melanoma</article-title><source>Nature</source><year>2011</year><month>3</month><volume>471</volume><issue>7339</issue><fpage>518</fpage><lpage>522</lpage><pub-id pub-id-type="pmid">21430780</pub-id></element-citation></ref><ref id="B28-ceo-6-219"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kari</surname><given-names>G</given-names></name><name><surname>Rodeck</surname><given-names>U</given-names></name><name><surname>Dicker</surname><given-names>AP</given-names></name></person-group><article-title>Zebrafish: an emerging model system for human disease and drug discovery</article-title><source>Clin Pharmacol Ther</source><year>2007</year><month>7</month><volume>82</volume><issue>1</issue><fpage>70</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">17495877</pub-id></element-citation></ref><ref id="B29-ceo-6-219"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>LL</given-names></name><name><surname>Cunningham</surname><given-names>LL</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name><name><surname>Rubel</surname><given-names>EW</given-names></name><name><surname>Ou</surname><given-names>HC</given-names></name></person-group><article-title>Using the zebrafish lateral line to screen for ototoxicity</article-title><source>J Assoc Res Otolaryngol</source><year>2008</year><month>6</month><volume>9</volume><issue>2</issue><fpage>178</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">18408970</pub-id></element-citation></ref><ref id="B30-ceo-6-219"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Roeser</surname><given-names>T</given-names></name><name><surname>Staub</surname><given-names>W</given-names></name><name><surname>Baier</surname><given-names>H</given-names></name></person-group><article-title>A GFP-based genetic screen reveals mutations that disrupt the architecture of the zebrafish retinotectal projection</article-title><source>Development</source><year>2005</year><month>7</month><volume>132</volume><issue>13</issue><fpage>2955</fpage><lpage>2967</lpage><pub-id pub-id-type="pmid">15930106</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1-ceo-6-219" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Quantitative assay of neuromasts in zebrafish. Hair cells from four neuromasts (supraorbital 1, supraorbital 2, otic 1, and occipital 1 were counted. Treatment of zebrafish with 125 &#xB5;M Neo for 1 hour significantly decreased the number of hair cells in the neuromasts. TMZ protected against neomycin-induced hair cell loss in neuromasts (NC, 13.1&#xB1;0.9 cells; 125 &#xB5;M Neo only 4.2&#xB1;0.5 cells; TMZ 10 &#xB5;M, 4.2&#xB1;0.7 cells; TMZ 100 &#xB5;M, 4.1&#xB1;0.6 cells; TMZ 500 &#xB5;M, 9.4&#xB1;1.1 cells; TMZ 1,000 &#xB5;M, 11.2&#xB1;0.4 cells; TMZ 1,500 &#xB5;M, 10.0&#xB1;0.7 cells; TMZ 2,000 &#xB5;M, 8.7&#xB1;1.7 cells; n=10; <italic>P</italic>&lt;0.05). NC, negative control; Neo, neomycin; TMZ, trimetazidine.</p></caption><graphic xlink:href="ceo-6-219-g001"/></fig><fig id="F2-ceo-6-219" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Confocal microscopy (&#xD7;40). The 5-dpf transgenic zebrafish were treated simultaneously with 125 &#xB5;M Neo and 1,000 &#xB5;M TMZ for 1 hour. Treatment with 125 &#xB5;M Neo resulted in a significant decrease in the number of hair cells in the neuromasts, and TMZ protected against this neomycin-induced hair cell damage. TMZ, trimetazidine; SO1, supraorbital 1; SO2, supraorbital 2; O1, otic 1; OC1, occipital 1; NC, negative control; Neo, neomycin.</p></caption><graphic xlink:href="ceo-6-219-g002"/></fig><fig id="F3-ceo-6-219" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Evaluation of mitochondrial damage with DASPEI (fluorescent microscopy, O1, &#xD7;40). The 5-dpf wild-type zebrafish were treated with 125 &#xB5;M Neo and 1,000 &#xB5;M TMZ for 1 hour. Treatment with 125 &#xB5;M Neo resulted in a significant decrease in mitochondrial staining with DASPEI, and this mitochondrial damage was prevented by TMZ. NC, negative control; Neo, neomycin; TMZ, trimetazidine; O1, otic.</p></caption><graphic xlink:href="ceo-6-219-g003"/></fig><fig id="F4-ceo-6-219" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay (fluorescent microscope, &#xD7;10). Neo-induced apoptotic cells were confirmed by the TUNEL assay. Apoptotic cells are marked as light red dots in red-colored fish after the TUNEL reaction under a fluorescent microscope (arrow indicates TUNEL-positive cells). No light-red dots were found in the NC group. A comparison of the color intensity between the group treated with 125 &#xB5;M Neo and the group treated with 1,000 &#xB5;M TMZ for 1 hour showed that TMZ significantly decreased the number of TUNEL-positive cells and protected against Neo-induced apoptotic cell death of the neuromast hair cells (green-colored fish of right column, control for TUNEL reaction; red-colored fish of middle column, TUNEL reaction; green- and red-colored fish of left column, combination of control and TUNEL reaction). NC, negative control; Neo, neomycin; TMZ, trimetazidine.</p></caption><graphic xlink:href="ceo-6-219-g004"/></fig><fig id="F5-ceo-6-219" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Scanning electron microscopy (SEM; O1, &#xD7;3,000). Compared to control neuromasts, neuromasts in zebrafish treated with 125 &#xB5;M Neo for 1 hour showed severe morphological damage to stereocilia and kinocilium under SEM. However, this damage was prevented by TMZ. NC, negative control; Neo, neomycin; TMZ, trimetazidine, O1, otic.</p></caption><graphic xlink:href="ceo-6-219-g005"/></fig></floats-group></article>
